Crohn's Disease Treatment Global Market Report 2025

Description

Crohn's disease treatment encompasses medical interventions and therapies designed to manage Crohn's disease, a chronic gastrointestinal condition. The primary goals of treatment are to mitigate inflammation in the intestines, prevent symptom flare-ups, and sustain overall recovery.

The key drug categories in Crohn's disease treatment include antibiotics, aminosalicylates, corticosteroids, immunomodulators, and others. Antibiotics are pharmaceuticals utilized for both treating and preventing bacterial infections. These drugs are accessible through diverse channels, including hospital pharmacies, retail pharmacies, and online pharmacies. They find applications in various medical conditions such as neuropathic pain, fibromyalgia, chronic back pain, arthritic pain, migraine, post-operative pain, cancer pain, and other therapeutic areas.

The Crohn's disease treatment market research report is one of a series of new reports from The Business Research Company that provides Crohn's disease treatment market statistics, including Crohn's disease treatment industry global market size, regional shares, competitors with a Crohn's disease treatment market share, detailed Crohn's disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the Crohn's disease treatment industry. This Crohn's disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The crohn's disease treatment market size has grown strongly in recent years. It will grow from$12.45 billion in 2024 to $13.23 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increased disease prevalence, advancements in diagnostic techniques, biological therapies adoption, patient awareness and education, clinical research and development

The crohn's disease treatment market size is expected to see strong growth in the next few years. It will grow to $17.67 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to personalized medicine approaches, biologics market expansion, evolving treatment guidelines, increased healthcare spending, collaborative research efforts. Major trends in the forecast period include telemedicine for patient management, research on immune modulation strategies, patient-centric care models, integration of digital health solutions.

The rising prevalence of inflammatory bowel disorders is expected to drive growth in the Crohn's disease treatment market. Inflammatory bowel disorders include a group of chronic conditions characterized by inflammation in the gastrointestinal tract, which can affect any part of the digestive system, from the mouth to the anus. Treatments for Crohn's disease aim to reduce intestinal inflammation, prevent symptom flare-ups, and maintain remission. For example, in September 2023, the National Center for Biotechnology Information reported a rise in the prevalence of Crohn's disease and ulcerative colitis, with inflammatory bowel disease projected at 825 cases per 100,000 people in 2023-410 for Crohn's disease and 414 for ulcerative colitis and IBD-unclassified. Consequently, the increasing occurrence of these disorders is contributing to the growth of the Crohn's disease treatment market.

The growing aging population is anticipated to drive the expansion of the Crohn's disease treatment market. This demographic shift, characterized by an increasing proportion of elderly individuals, contributes to a higher prevalence of chronic conditions, including Crohn's disease, thereby raising the demand for treatments. For example, in January 2024, the Population Reference Bureau (PRB), a U.S.-based nonprofit, projected that the number of Americans aged 65 and older would increase from 58 million in 2022 to 82 million by 2050, a 47% rise. This age group's share of the population is expected to grow from 17% to 23%. Thus, the expanding aging population is boosting the Crohn's disease treatment market.

Leading companies in the Crohn's disease treatment market are advancing drug innovation and securing approvals, including for biosimilars like ustekinumab, to provide more effective and accessible treatment options that enhance patient outcomes and quality of life. Biosimilar ustekinumab is a biologic closely matching the original ustekinumab (a monoclonal antibody) used for autoimmune conditions. For instance, in July 2024, Switzerland-based Sandoz International GmbH launched Pyzchiva (ustekinumab) across Europe, making it the first ustekinumab biosimilar available in all strengths, including a 130 mg vial for Crohn's disease. This treatment is approved for adults and children over six with plaque psoriasis, psoriatic arthritis, and Crohn's disease, expanding Sandoz's immunology portfolio and enhancing access to affordable treatments for chronic inflammatory diseases.

Major companies in the Crohn's disease treatment market are directing efforts toward the development of new treatment options, including oral medications for moderate-severe Crohn's disease. In March 2022, AbbVie Inc. announced FDA approval for RINVOQ (upadacitinib), the first once-daily oral medication for patients with moderate-to-severe Crohn's disease. This selective Janus kinase (JAK) inhibitor precisely targets inflammation pathways, offering a potential reduction in adverse events linked to immunosuppression.

In March 2022, Pfizer Inc., a prominent US-based biopharmaceutical company, completed the acquisition of Arena Pharmaceuticals Inc. for approximately $6.7 billion. This strategic acquisition aimed to expand Pfizer's inflammation and immunology therapeutic area pipeline portfolio, encompassing conditions such as atopic dermatitis, eosinophilic esophagitis, ulcerative colitis, and Crohn's disease. Arena Pharmaceuticals Inc., a US-based biopharmaceutical company, significantly contributes to Pfizer's presence and offerings in the Crohn's disease treatment market.

Major companies operating in the crohn's disease treatment market include AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Bristol-Myers Squibb Company, Galapagos NV, Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Arena Pharmaceuticals Inc.

North America was the largest region in the global Crohn's disease treatment market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the crohn's disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the crohn's disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The crohn's disease treatment market consists of sales of vedolizumab, methotrexate, and infliximab. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Crohn's Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on crohn's disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for crohn's disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The crohn's disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: Antibiotics; Amino Salicylates; Corticosteroids; Immunomodulators; Other Drug Types
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Application: Neuropathic Pain; Fibromyalgia; Chronic Back Pain; Arthritic Pain; Migraine Post-Operative Pain; Cancer Pain; Other Applications
Subsegments:
1) By Antibiotics: Metronidazole; Ciprofloxacin; Other Antibiotics
2) By Amino Salicylates: Mesalamine; Sulfasalazine; Other Amino Salicylates
3) By Corticosteroids: Prednisone; Budesonide; Other Corticosteroids
4) By Immunomodulators: Azathioprine; Methotrexate; Mercaptopurine
5) By Other Drug Types: Biologics; Small Molecules; Other Treatments
Companies Mentioned: AbbVie Inc.; AstraZeneca plc; Boehringer Ingelheim GmbH; Eli Lilly and Company; Janssen Pharmaceuticals
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r24065

1. Executive Summary

2. Crohn's Disease Treatment Market Characteristics

3. Crohn's Disease Treatment Market Trends And Strategies

4. Crohn's Disease Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Crohn's Disease Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Crohn's Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Crohn's Disease Treatment Market Growth Rate Analysis
5.4. Global Crohn's Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Crohn's Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Crohn's Disease Treatment Total Addressable Market (TAM)

6. Crohn's Disease Treatment Market Segmentation

6.1. Global Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antibiotics
Amino Salicylates
Corticosteroids
Immunomodulators
Other Drug Types
6.2. Global Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.3. Global Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Neuropathic Pain
Fibromyalgia
Chronic Back Pain
Arthritic Pain
Migraine Post-Operative Pain
Cancer Pain
Other Applications
6.4. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Metronidazole
Ciprofloxacin
Other Antibiotics
6.5. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Amino Salicylates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mesalamine
Sulfasalazine
Other Amino Salicylates
6.6. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prednisone
Budesonide
Other Corticosteroids
6.7. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Azathioprine
Methotrexate
Mercaptopurine
6.8. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biologics
Small Molecules
Other Treatments

7. Crohn's Disease Treatment Market Regional And Country Analysis

7.1. Global Crohn's Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Crohn's Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Crohn's Disease Treatment Market

8.1. Asia-Pacific Crohn's Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Crohn's Disease Treatment Market

9.1. China Crohn's Disease Treatment Market Overview
9.2. China Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Crohn's Disease Treatment Market

10.1. India Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Crohn's Disease Treatment Market

11.1. Japan Crohn's Disease Treatment Market Overview
11.2. Japan Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Crohn's Disease Treatment Market

12.1. Australia Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Crohn's Disease Treatment Market

13.1. Indonesia Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Crohn's Disease Treatment Market

14.1. South Korea Crohn's Disease Treatment Market Overview
14.2. South Korea Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Crohn's Disease Treatment Market

15.1. Western Europe Crohn's Disease Treatment Market Overview
15.2. Western Europe Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Crohn's Disease Treatment Market

16.1. UK Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Crohn's Disease Treatment Market

17.1. Germany Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Crohn's Disease Treatment Market

18.1. France Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Crohn's Disease Treatment Market

19.1. Italy Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Crohn's Disease Treatment Market

20.1. Spain Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Crohn's Disease Treatment Market

21.1. Eastern Europe Crohn's Disease Treatment Market Overview
21.2. Eastern Europe Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Crohn's Disease Treatment Market

22.1. Russia Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Crohn's Disease Treatment Market

23.1. North America Crohn's Disease Treatment Market Overview
23.2. North America Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Crohn's Disease Treatment Market

24.1. USA Crohn's Disease Treatment Market Overview
24.2. USA Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Crohn's Disease Treatment Market

25.1. Canada Crohn's Disease Treatment Market Overview
25.2. Canada Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Crohn's Disease Treatment Market

26.1. South America Crohn's Disease Treatment Market Overview
26.2. South America Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Crohn's Disease Treatment Market

27.1. Brazil Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Crohn's Disease Treatment Market

28.1. Middle East Crohn's Disease Treatment Market Overview
28.2. Middle East Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Crohn's Disease Treatment Market

29.1. Africa Crohn's Disease Treatment Market Overview
29.2. Africa Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Crohn's Disease Treatment Market Competitive Landscape And Company Profiles

30.1. Crohn's Disease Treatment Market Competitive Landscape
30.2. Crohn's Disease Treatment Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Janssen Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

31. Crohn's Disease Treatment Market Other Major And Innovative Companies

31.1. Pfizer Inc.
31.2. Takeda Pharmaceutical Company Limited
31.3. Biogen Inc.
31.4. Bristol-Myers Squibb Company
31.5. Galapagos NV
31.6. Novartis AG
31.7. Sanofi S.A.
31.8. F. Hoffmann-La Roche Ltd.
31.9. Teva Pharmaceutical Industries Ltd.
31.10. Merck & Co. Inc.
31.11. Mylan N.V.
31.12. Glenmark Pharmaceuticals
31.13. Tillotts Pharma AG
31.14. Dr. Falk Pharma GmbH
31.15. Shire Pharmaceuticals

32. Global Crohn's Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Crohn's Disease Treatment Market

34. Recent Developments In The Crohn's Disease Treatment Market

35. Crohn's Disease Treatment Market High Potential Countries, Segments and Strategies

35.1 Crohn's Disease Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Crohn's Disease Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Crohn's Disease Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer